Companies / Rhythm Pharmaceuticals, Inc. / Activity
Activity — Rhythm Pharmaceuticals, Inc.
109 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 1, 2026 | Meeker David P CEO | Other | Common Stock | $3.44M | -32K -11.65% | 239,016 0.35% of shares | low |
| Feb 1, 2026 | Smith Hunter C Executive | Other | Common Stock | $1.17M | -11K -7.52% | 132,165 0.19% of shares | low |
| Feb 1, 2026 | Lee Jennifer Kayden Executive | Other | Common Stock | $1.01M | -9K -32.44% | 19,233 0.03% of shares | low |
| Feb 1, 2026 | Shulman Joseph Executive | Other | Common Stock | $709.2K | -7K -25.54% | 18,970 0.03% of shares | low |
| Feb 1, 2026 | Cramer Pamela J. Executive | Other | Common Stock | $515.6K | -5K -13.87% | 29,376 0.04% of shares | low |
| Mar 4, 2026 | German Christopher Paul Executive | Sell | Common Stock | $502.8K | -6K -97.23% | 160 <0.01% of shares | medium |
| May 15, 2026 | German Christopher Paul Executive | Sell | Common Stock | $428.1K | -5K -100.00% | 0 0.00% of shares | medium |
| Feb 5, 2026 | Smith Hunter C Executive | Sell | Common Stock | $358.6K | -3K -2.62% | 125,537 0.18% of shares | medium |
| Feb 11, 2026 | Smith Hunter C Executive | Sell | Common Stock | $222.9K | -2K -1.84% | 120,558 0.18% of shares | medium |
| Feb 1, 2026 | Garfield Alastair Executive | Other | Common Stock | $220.8K | -2K -20.70% | 7,763 0.01% of shares | low |
| Feb 10, 2026 | Smith Hunter C Executive | Sell | Common Stock | $196.4K | -2K -1.52% | 123,624 0.18% of shares | medium |
| Feb 19, 2026 | Smith Hunter C Executive | Sell | Common Stock | $170.8K | -2K -1.49% | 111,897 0.16% of shares | medium |
| Feb 4, 2026 | Smith Hunter C Executive | Sell | Common Stock | $157.1K | -2K -1.13% | 130,665 0.19% of shares | medium |
| Feb 19, 2026 | Smith Hunter C Executive | Sell | Common Stock | $131.2K | -1K -1.14% | 113,589 0.16% of shares | medium |
| Feb 1, 2026 | German Christopher Paul Executive | Other | Common Stock | $124.0K | -1K -24.90% | 3,433 <0.01% of shares | low |
| Feb 17, 2026 | Smith Hunter C Executive | Sell | Common Stock | $119.3K | -1K -1.01% | 117,266 0.17% of shares | medium |
| Feb 17, 2026 | Smith Hunter C Executive | Sell | Common Stock | $110.1K | -1K -0.92% | 115,097 0.17% of shares | medium |
| Feb 4, 2026 | Smith Hunter C Executive | Sell | Common Stock | $106.6K | -1K -0.77% | 129,665 0.19% of shares | medium |
| May 15, 2026 | German Christopher Paul Executive | Exercise | Common Stock | $95.6K | +2K +839.30% | 1,888 <0.01% of shares | low |
| Feb 17, 2026 | Smith Hunter C Executive | Sell | Common Stock | $91.5K | -900 -0.77% | 116,166 0.17% of shares | low |
| Feb 19, 2026 | Smith Hunter C Executive | Sell | Common Stock | $81.7K | -800 -0.71% | 111,097 0.16% of shares | low |
| Feb 4, 2026 | Smith Hunter C Executive | Sell | Common Stock | $80.4K | -747 -0.58% | 128,918 0.19% of shares | low |
| Feb 12, 2026 | Smith Hunter C Executive | Sell | Common Stock | $79.2K | -800 -0.67% | 118,566 0.17% of shares | low |
| Feb 10, 2026 | Smith Hunter C Executive | Sell | Common Stock | $72.6K | -700 -0.57% | 122,924 0.18% of shares | low |
| May 15, 2026 | German Christopher Paul Executive | Exercise | Common Stock | $66.4K | +1K +71.45% | 3,237 <0.01% of shares | low |
| Feb 19, 2026 | Smith Hunter C Executive | Sell | Common Stock | $60.4K | -585 -0.53% | 110,512 0.16% of shares | low |
| Mar 2, 2026 | Smith Hunter C Executive | Exercise | Common Stock | $41.5K | +6K +5.52% | 116,611 0.17% of shares | low |
| Feb 11, 2026 | Smith Hunter C Executive | Sell | Common Stock | $39.8K | -400 -0.33% | 120,158 0.17% of shares | low |
| Feb 12, 2026 | Smith Hunter C Executive | Sell | Common Stock | $39.1K | -400 -0.33% | 119,366 0.17% of shares | low |
| Mar 1, 2026 | German Christopher Paul Executive | Other | Common Stock | $32.5K | -342 -7.44% | 4,253 <0.01% of shares | low |
| Feb 12, 2026 | Smith Hunter C Executive | Sell | Common Stock | $28.1K | -292 -0.24% | 119,766 0.17% of shares | low |
| Mar 4, 2026 | German Christopher Paul Executive | Exercise | Common Stock | $27.0K | +2K +35.27% | 5,753 <0.01% of shares | low |
| May 15, 2026 | German Christopher Paul Executive | Exercise | Common Stock | $25.3K | +1K +43.44% | 4,643 <0.01% of shares | low |
| Feb 17, 2026 | Smith Hunter C Executive | Sell | Common Stock | $20.8K | -200 -0.17% | 114,897 0.17% of shares | low |
| Feb 17, 2026 | Smith Hunter C Executive | Sell | Common Stock | $20.1K | -200 -0.17% | 117,066 0.17% of shares | low |
| Feb 10, 2026 | Smith Hunter C Executive | Sell | Common Stock | $10.5K | -100 -0.08% | 122,824 0.18% of shares | low |
| Feb 11, 2026 | Smith Hunter C Executive | Sell | Common Stock | $10.1K | -100 -0.08% | 120,058 0.17% of shares | low |
| Feb 12, 2026 | Smith Hunter C Executive | Sell | Common Stock | $10.0K | -100 -0.08% | 118,466 0.17% of shares | low |
| Mar 12, 2026 | Mathers Edward T Director | Other | Common Stock | $0 | +4K +42.12% | 14,168 0.02% of shares | low |
| Mar 2, 2026 | Mathers Edward T Director | Other | Common Stock | $0 | +4K +72.74% | 9,969 0.01% of shares | low |
| Jun 24, 2026 | Jean Christophe Director | Grant | Restricted Stock Units | — | +2K | 2,324 <0.01% of shares | low |
| Jun 24, 2026 | Jean Christophe Director | Grant | Stock Option (right to buy) | — | +4K | 3,691 <0.01% of shares | low |
| Jun 23, 2026 | Jean Christophe Director | Exercise | Restricted Stock Units | — | -5K -100.00% | 0 0.00% of shares | low |
| Jun 23, 2026 | Jean Christophe Director | Exercise | Common Stock | — | +5K +67.31% | 11,712 0.02% of shares | low |
| Apr 1, 2026 | Popovits Kimberly J Director | Grant | Stock Options (Right to Buy) | — | +10K | 10,257 0.01% of shares | low |
| Apr 1, 2026 | Popovits Kimberly J Director | Grant | Restricted Stock Units | — | +7K | 6,808 <0.01% of shares | low |
| May 15, 2026 | German Christopher Paul Executive | Exercise | Stock Options (Right to Buy) | — | -1K -37.68% | 2,325 <0.01% of shares | low |
| May 15, 2026 | German Christopher Paul Executive | Exercise | Stock Options (Right to Buy) | — | -1K -33.31% | 2,701 <0.01% of shares | low |
| May 15, 2026 | German Christopher Paul Executive | Exercise | Stock Options (Right to Buy) | — | -2K -31.24% | 3,713 <0.01% of shares | low |
| Jun 24, 2026 | Good Jennifer L Director | Grant | Restricted Stock Units | — | +2K | 2,324 <0.01% of shares | low |